Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Comput Biol Med ; 175: 108368, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38663351

ABSTRACT

BACKGROUND: The issue of using deep learning to obtain accurate gross tumor volume (GTV) and metastatic lymph nodes (MLN) segmentation for nasopharyngeal carcinoma (NPC) on heterogeneous magnetic resonance imaging (MRI) images with limited labeling remains unsolved. METHOD: We collected 918 patients with MRI images from three hospitals to develop and validate models and proposed a semi-supervised framework for the fine delineation of multi-center NPC boundaries by integrating uncertainty-based implicit neural representations named SIMN. The framework utilizes the deep mutual learning approach with CNN and Transformer, incorporating dynamic thresholds. Additionally, domain adaptive algorithms are employed to enhance the performance. RESULTS: SIMN predictions have a high overlap ratio with the ground truth. Under the 20 % labeled cases, for the internal test cohorts, the average DSC in GTV and MLN are 0.7981 and 0.7804, respectively; for external test cohort Wu Zhou Red Cross Hospital, the average DSC in GTV and MLN are 0.7217 and 0.7581, respectively; for external test cohorts First People Hospital of Foshan, the average DSC in GTV and MLN are 0.7004 and 0.7692, respectively. No significant differences are found in DSC, HD95, ASD, and Recall for patients with different clinical categories. Moreover, SIMN outperformed existing classical semi-supervised methods. CONCLUSIONS: SIMN showed a highly accurate GTV and MLN segmentation for NPC on multi-center MRI images under Semi-Supervised Learning (SSL), which can easily transfer to other centers without fine-tuning. It suggests that it has the potential to act as a generalized delineation solution for heterogeneous MRI images with limited labels in clinical deployment.


Subject(s)
Magnetic Resonance Imaging , Nasopharyngeal Carcinoma , Nasopharyngeal Neoplasms , Humans , Magnetic Resonance Imaging/methods , Nasopharyngeal Carcinoma/diagnostic imaging , Nasopharyngeal Neoplasms/diagnostic imaging , Male , Female , Middle Aged , Adult , Deep Learning , Algorithms , Image Interpretation, Computer-Assisted/methods , Neural Networks, Computer
2.
Diagnostics (Basel) ; 14(4)2024 Feb 17.
Article in English | MEDLINE | ID: mdl-38396486

ABSTRACT

Objective: To comprehensively capture intra-tumor heterogeneity in head and neck cancer (HNC) and maximize the use of valid information collected in the clinical field, we propose a novel multi-modal image-text fusion strategy aimed at improving prognosis. Method: We have developed a tailored diagnostic algorithm for HNC, leveraging a deep learning-based model that integrates both image and clinical text information. For the image fusion part, we used the cross-attention mechanism to fuse the image information between PET and CT, and for the fusion of text and image, we used the Q-former architecture to fuse the text and image information. We also improved the traditional prognostic model by introducing time as a variable in the construction of the model, and finally obtained the corresponding prognostic results. Result: We assessed the efficacy of our methodology through the compilation of a multicenter dataset, achieving commendable outcomes in multicenter validations. Notably, our results for metastasis-free survival (MFS), recurrence-free survival (RFS), overall survival (OS), and progression-free survival (PFS) were as follows: 0.796, 0.626, 0.641, and 0.691. Our results demonstrate a notable superiority over the utilization of CT and PET independently, and exceed the result derived without the clinical textual information. Conclusions: Our model not only validates the effectiveness of multi-modal fusion in aiding diagnosis, but also provides insights for optimizing survival analysis. The study underscores the potential of our approach in enhancing prognosis and contributing to the advancement of personalized medicine in HNC.

SELECTION OF CITATIONS
SEARCH DETAIL
...